Annual ROE
-1273.39%
-1035.93%-436.25%
31 December 2023
Summary:
Eupraxia Pharmaceuticals Common Stock annual return on equity is currently -1273.39%, with the most recent change of -1035.93% (-436.25%) on 31 December 2023. During the last 3 years, it has fallen by -1292.24% (-6855.38%). EPRX annual ROE is now -1164.26% below its all-time high of 119.65%, reached on 01 December 2018.EPRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-244.79%
-24.98%-11.36%
01 September 2024
Summary:
Eupraxia Pharmaceuticals Common Stock quarterly return on equity is currently -244.79%, with the most recent change of -24.98% (-11.36%) on 01 September 2024. Over the past year, it has increased by +58.51% (+19.29%). EPRX quarterly ROE is now -221.05% below its all-time high of 202.23%, reached on 01 March 2021.EPRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPRX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -436.3% | +19.3% |
| 3 y3 years | -6855.4% | -75.2% |
| 5 y5 years | -1164.3% | - |
EPRX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6855.4% | at low | -206.8% | +41.1% |
| 5 y | 5 years | -1164.3% | at low | -221.1% | +49.6% |
| alltime | all time | -1164.3% | at low | -221.1% | +49.6% |
Eupraxia Pharmaceuticals Common Stock ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -244.79%(+11.4%) |
| June 2024 | - | -219.81%(-27.8%) |
| Mar 2024 | - | -304.35%(-26.8%) |
| Dec 2023 | -1273.39%(+436.3%) | -415.66%(+37.0%) |
| Sept 2023 | - | -303.30%(+12.7%) |
| June 2023 | - | -269.09%(+81.2%) |
| Mar 2023 | - | -148.47%(+4.5%) |
| Dec 2022 | -237.46% | - |
| Dec 2022 | - | -142.09%(+56.9%) |
| Sept 2022 | - | -90.55%(+5.3%) |
| June 2022 | - | -86.00%(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -79.79%(-15.6%) |
| Dec 2021 | -112.77%(-698.2%) | -94.50%(-32.4%) |
| Sept 2021 | - | -139.73%(-71.2%) |
| June 2021 | - | -485.90%(-340.3%) |
| Mar 2021 | - | 202.23%(+987.8%) |
| Dec 2020 | 18.85%(-53.5%) | 18.59%(-19.5%) |
| Sept 2020 | - | 23.08%(-25.2%) |
| June 2020 | - | 30.86%(+20.8%) |
| Mar 2020 | - | 25.54%(+77.7%) |
| Dec 2019 | 40.57%(-66.1%) | 14.37% |
| Dec 2018 | 119.65%(-265.7%) | - |
| Dec 2017 | -72.22% | - |
FAQ
- What is Eupraxia Pharmaceuticals Common Stock annual return on equity?
- What is the all time high annual ROE for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock annual ROE year-on-year change?
- What is Eupraxia Pharmaceuticals Common Stock quarterly return on equity?
- What is the all time high quarterly ROE for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock quarterly ROE year-on-year change?
What is Eupraxia Pharmaceuticals Common Stock annual return on equity?
The current annual ROE of EPRX is -1273.39%
What is the all time high annual ROE for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high annual return on equity is 119.65%
What is Eupraxia Pharmaceuticals Common Stock annual ROE year-on-year change?
Over the past year, EPRX annual return on equity has changed by -1035.93% (-436.25%)
What is Eupraxia Pharmaceuticals Common Stock quarterly return on equity?
The current quarterly ROE of EPRX is -244.79%
What is the all time high quarterly ROE for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high quarterly return on equity is 202.23%
What is Eupraxia Pharmaceuticals Common Stock quarterly ROE year-on-year change?
Over the past year, EPRX quarterly return on equity has changed by +58.51% (+19.29%)